Requirement for Innate Immunity and CD90(+) NK1.1(−) Lymphocytes to Treat Established Melanoma with Chemo-Immunotherapy

We sought to define cellular immune mechanisms of synergy between tumor-antigen–targeted monoclonal antibodies and chemotherapy. Established B16 melanoma in mice was treated with cytotoxic doses of cyclophosphamide in combination with an antibody targeting tyrosinase-related protein 1 (αTRP1), a nat...

全面介紹

Na minha lista:
書目詳細資料
發表在:Cancer Immunol Res
Main Authors: Moskalenko, Marina, Pan, Michael, Fu, Yichun, de Moll, Ellen H., Hashimoto, Daigo, Mortha, Arthur, Leboeuf, Marylene, Jayaraman, Padmini, Bernardo, Sebastian, Sikora, Andrew G., Wolchok, Jedd, Bhardwaj, Nina, Merad, Miriam, Saenger, Yvonne
格式: Artigo
語言:Inglês
出版: 2015
主題:
Article
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC4690202/
https://ncbi.nlm.nih.gov/pubmed/25600438
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/2326-6066.CIR-14-0120
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍